journal article Jun 30, 2011

A Comparative Study of Neural and Mesenchymal Stem Cell-Based Carriers for Oncolytic Adenovirus in a Model of Malignant Glioma

View at Publisher Save 10.1021/mp200161f
Topics

No keywords indexed for this article. Browse by subject →

References
45
[1]
Deorah S. Neurosurg. Focus (2006) 10.3171/foc.2006.20.4.e1
[2]
Lesniak M. S. Technol. Cancer Res. Treat. (2005) 10.1177/153303460500400409
[3]
Aboody K. S. Proc. Natl. Acad. Sci. U.S.A. (2000) 10.1073/pnas.97.23.12846
[4]
Benedetti S. Nat. Med. (2000) 10.1038/74710
[5]
Herrlinger U. Mol. Ther. (2000) 10.1006/mthe.2000.0046
[6]
Nakamura K. Gene Ther. (2004) 10.1038/sj.gt.3302276
[7]
Tyler M. A. Gene Ther. (2009) 10.1038/gt.2008.165
[8]
Willmon C. Mol. Ther. (2009) 10.1038/mt.2009.194
[9]
Ahmed A. Nat. Biotechnol. (2003) 10.1038/nbt835
[10]
Sonabend A. M. Neurosurg. Focus (2006) 10.3171/foc.2006.20.4.1
[11]
Fisher K. Curr. Opin. Mol. Ther. (2006)
[12]
Coukos G. Clin. Cancer Res. (1999)
[13]
Mader E. K. Clin. Cancer Res. (2009) 10.1158/1078-0432.ccr-09-1292
[14]
Ehtesham M. Neurosurg. Focus (2005) 10.3171/foc.2005.19.3.6
[15]
Brustle O. Proc. Natl. Acad. Sci. U.S.A. (1997) 10.1073/pnas.94.26.14809
[16]
Caplan A. I. Clin. Plast. Surg. (1994) 10.1016/s0094-1298(20)31020-8
[17]
Gregory C. A. Sci. STKE (2005) 10.1126/stke.2942005pe37
[18]
Pittenger M. F. Science (1999) 10.1126/science.284.5411.143
[19]
Ahmed A. U. Curr. Opin. Mol. Ther. (2010)
[20]
Improved monomeric red, orange and yellow fluorescent proteins derived from Discosoma sp. red fluorescent protein

Nathan C Shaner, Robert E Campbell, Paul A Steinbach et al.

Nature Biotechnology 2004 10.1038/nbt1037
[21]
Deregowski V. Methods Mol. Biol. (2008) 10.1007/978-1-59745-104-8_12
[22]
Ulasov I. V. Hum. Gene Ther. (2007) 10.1089/hum.2007.002
[23]
Sonabend A. M. Stem Cells (2008) 10.1634/stemcells.2007-0758
[24]
Ulasov I. V. Cancer Biol. Ther. (2007) 10.4161/cbt.6.5.3957
[25]
Yu S. C. Cancer Lett. (2008) 10.1016/j.canlet.2008.02.010
[26]
Muruve D. A. Hum. Gene Ther. (2004) 10.1089/hum.2004.15.1157
[27]
Einstein O. Arch. Neurol. (2008) 10.1001/archneur.65.4.452
[28]
Pluchino S. Nature (2003) 10.1038/nature01552
[29]
Pluchino S. Nature (2005) 10.1038/nature03889
[30]
Sun L. J. Clin. Invest. (2004) 10.1172/jci200420001
[31]
Carbajal K. S. Proc. Natl. Acad. Sci. U.S.A. (2010) 10.1073/pnas.1006375107
[32]
Heese O. Neuro. Oncol. (2005) 10.1215/s1152851704000754
[33]
Schmidt N. O. Brain Res. (2009) 10.1016/j.brainres.2009.02.065
[34]
Magge S. N. J. Neurosci. Res. (2009) 10.1002/jnr.21983
[36]
Xu Q. Mol. Cancer Ther. (2009) 10.1158/1535-7163.mct-09-0273
[37]
Guan Y. Exp. Mol. Pathol. (2008) 10.1016/j.yexmp.2008.07.003
[38]
Shi Y. Cell Res. (2010) 10.1038/cr.2010.44
[39]
Fainstein N. Mol. Cell. Neurosci. (2008) 10.1016/j.mcn.2008.07.007
[40]
Jones B. J. Exp. Hematol. (2008) 10.1016/j.exphem.2008.03.006
[41]
Ahmed A. U. Mol. Ther. (2010)
[42]
Ferguson S. D. Discovery Med. (2010)
[43]
Aboody K. S. Gene Ther. (2008) 10.1038/gt.2008.41
[44]
Li T. S. Circulation (2009)
[45]
Thu M. S. PLoS One (2009) 10.1371/journal.pone.0007218
Cited By
116
Pharmaceutical Science Advances
Related

You May Also Like

Bioavailability of Curcumin: Problems and Promises

Preetha Anand, Ajaikumar B. Kunnumakkara · 2007

4,527 citations

pH-Responsive Nanoparticles for Drug Delivery

Weiwei Gao, Juliana C. N. Chan · 2010

917 citations

Gold Nanoparticles in Cancer Treatment

Krzysztof Sztandera, Michał Gorzkiewicz · 2018

539 citations